339 related articles for article (PubMed ID: 23629003)
1. HLA engineering of human pluripotent stem cells.
Riolobos L; Hirata RK; Turtle CJ; Wang PR; Gornalusse GG; Zavajlevski M; Riddell SR; Russell DW
Mol Ther; 2013 Jun; 21(6):1232-41. PubMed ID: 23629003
[TBL] [Abstract][Full Text] [Related]
2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
3. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
4. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
[TBL] [Abstract][Full Text] [Related]
5. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Gornalusse GG; Hirata RK; Funk SE; Riolobos L; Lopes VS; Manske G; Prunkard D; Colunga AG; Hanafi LA; Clegg DO; Turtle C; Russell DW
Nat Biotechnol; 2017 Aug; 35(8):765-772. PubMed ID: 28504668
[TBL] [Abstract][Full Text] [Related]
6. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
7. Engineering of human pluripotent stem cells by AAV-mediated gene targeting.
Khan IF; Hirata RK; Wang PR; Li Y; Kho J; Nelson A; Huo Y; Zavaljevski M; Ware C; Russell DW
Mol Ther; 2010 Jun; 18(6):1192-9. PubMed ID: 20407427
[TBL] [Abstract][Full Text] [Related]
8. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin.
Lu P; Chen J; He L; Ren J; Chen H; Rao L; Zhuang Q; Li H; Li L; Bao L; He J; Zhang W; Zhu F; Cui C; Xiao L
Stem Cell Rev Rep; 2013 Dec; 9(6):806-13. PubMed ID: 23934228
[TBL] [Abstract][Full Text] [Related]
9. Cryopreserved Human Oocytes and Cord Blood Cells Can Produce Somatic Cell Nuclear Transfer-Derived Pluripotent Stem Cells with a Homozygous HLA Type.
Lee JE; Lee JY; Park CH; Eum JH; Jung SK; Han AR; Seol DW; Lee JS; Shin HS; Im JH; Chun T; Ha K; Heo DR; Yoon TK; Lee DR
Stem Cell Reports; 2020 Jul; 15(1):171-184. PubMed ID: 32502464
[TBL] [Abstract][Full Text] [Related]
10. Enhanced gene targeting of adult and pluripotent stem cells using evolved adeno-associated virus.
Bartel MA; Schaffer DV
Methods Mol Biol; 2014; 1114():169-79. PubMed ID: 24557903
[TBL] [Abstract][Full Text] [Related]
11. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
[TBL] [Abstract][Full Text] [Related]
12. Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains.
Sharova LV; Sharov AA; Piao Y; Shaik N; Sullivan T; Stewart CL; Hogan BL; Ko MS
Dev Biol; 2007 Jul; 307(2):446-59. PubMed ID: 17560561
[TBL] [Abstract][Full Text] [Related]
13. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
[TBL] [Abstract][Full Text] [Related]
14. Gene targeting in human pluripotent stem cells.
Liu Y; Rao M
Methods Mol Biol; 2011; 767():355-67. PubMed ID: 21822888
[TBL] [Abstract][Full Text] [Related]
15. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
16. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure.
Lin G; OuYang Q; Zhou X; Gu Y; Yuan D; Li W; Liu G; Liu T; Lu G
Cell Res; 2007 Dec; 17(12):999-1007. PubMed ID: 18040289
[TBL] [Abstract][Full Text] [Related]
17. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
18. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
19. Derivation and characterization of embryonic stem cells lines derived from transgenic Fischer 344 and Dark Agouti rats.
Hong J; He H; Weiss ML
Stem Cells Dev; 2012 Jun; 21(9):1571-86. PubMed ID: 21995453
[TBL] [Abstract][Full Text] [Related]
20. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors.
Mitsui K; Suzuki K; Aizawa E; Kawase E; Suemori H; Nakatsuji N; Mitani K
Biochem Biophys Res Commun; 2009 Oct; 388(4):711-7. PubMed ID: 19695233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
